Table 4.
Outcome of IAC according to International Classification of Intraocular RB
| Authors (no.of eyes) | Eye salvage according to groups in % | ||||
|---|---|---|---|---|---|
| A | B | C | D | E | |
| Suzuki et al (408)12 | 100 | 88 | 65 | 45 | 30 |
| Abramson et al (120)24 | 100 | 100 | 100 | 100 | 90 |
| Chen et al (107)56 | NA | 100 | 100 | 78.5 | 62 |
| Shields et al (70)25 | NA | 100 | 100 | 94 | 36 |
| Ammanuel et al (43)58 | 0 | 90 | 64 | 69 | 50 |
| Ronjanaporn et al (27)61 | NA | 100 | 100 | 75 | 9 |
| Munier et al (25)63 | NA | NA | NA | 100 | NA |
| Tuncer et al (24)52 | NA | NA | NA | 67 | NA |
| Ghassemi et al (24)49 | NA | 100 | 0 | 72 | 66 |
| Thampi et al (20)46 | 100 | 100 | 100 | 50 | 33 |
| Ong et al (17)50 | NA | 67 | 100 | 100 | 57 |
| Parareda et al (12)48 | NA | 100 | 100 | 50 | NA |
| Leal-Leal et al (11)54 | NA | 50 | 100 | 30 | NA |
*Most ocular oncologists do not treat group A with IAC due to potential toxicities and they treat with local laser therapy like laser photocoagulation and cryotherapy